Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
Waters Community
NYSE:WAT Community
1
Narratives
written by author
0
Comments
on narratives written by author
10
Fair Values set
on narratives written by author
Create a narrative
Waters
Popular
Undervalued
Overvalued
Community Investing Ideas
Waters
AN
AnalystConsensusTarget
Consensus Narrative from 20 Analysts
Revitalized Portfolio And High-Growth Segments Will Drive Future Success In Analytical Instruments
Key Takeaways Waters is revitalizing its product portfolio, driving revenue growth through innovation and tapping into high-growth markets like GLP-1, PFAS testing, and generics in India. Improved financial positioning allows Waters to consider strategic M&A or share repurchases, enhancing earnings per share and shareholder value.
View narrative
US$393.19
FV
18.3% undervalued
intrinsic discount
5.66%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
9
users have followed this narrative
Updated
narrative
Your Valuation for
WAT
WAT
Waters
Your Fair Value
US$
Current Price
US$321.10
7.9% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
4b
2015
2018
2021
2024
2025
2027
2030
Revenue US$3.9b
Earnings US$833.3m
Advanced
Set Fair Value